MFN2 mutation |
T105M |
R94Q |
T105M |
R94Q |
MFN2 transgene promoter |
Hb9 |
Eno |
Rosa-STOP-MFN2T105M/CAG-CreERT2 |
Nestin-cre |
Thy1.2 |
Genotype |
Homozygous |
Heterozygous |
Homozygous (MitoCharc2) |
Heterozygous (MitoCharc1) |
Homozygous |
Heterozygous |
Y-linked |
Phenotype onset |
Severe congenital |
Mild congenital |
Mild late |
Mild late |
6 W post-tamoxifen induction |
Mild late |
Early |
Motor resistance (Rotarod test) |
Hindlimb muscles weakness but no alteration |
No alteration |
Frequent fall off |
Frequent fall off |
Not detectable |
Not significant |
Frequent fall off |
Grip strength |
/ |
/ |
/ |
/ |
/ |
/ |
Frequent fall off |
Gait (Noldus Catwalk) |
Defect in dorsi-flexion but no gaiting alteration |
No alteration |
Abnormal print length |
No alteration |
/ |
Abnormal print length |
Progressive gaiting worsening |
Axon (number, size, g-ratio) |
40% fewer axons in motor roots (L4 and L5) |
No alteration |
+ 55% of < 3.5 μm axons |
+ 40% of < 3.5 μm axons; Aδ fibers altered in the sciatic nerves |
/ |
No alteration |
Degeneration in tibialis muscle |
Muscle fiber |
Smaller anterior hindlimb muscles |
No alteration |
No alteration |
No alteration |
/ |
Smaller tibialis and soleus muscles |
/ |
Mitochondria (number, aggregates, axonal transport) |
Highly aggregation and clusters |
Highly aggregation and clusters |
N° mitochondria + 28% in < 3.5 μm axons |
N° mitochondria + 34% in < 3.5 μm axons |
Reduced number in tibialis axons |
No alteration |
Clusters and morphology abnormalities. No mitophagy |
Sensitive phenotype |
/ |
/ |
/ |
/ |
/ |
/ |
/ |